Taiwan · Delayed Price · Currency is TWD Handa Pharmaceuticals Statistics
Total Valuation
TPEX:6620 has a market cap or net worth of TWD 13.36 billion. The enterprise value is 9.70 billion.
| Market Cap | 13.36B |
| Enterprise Value | 9.70B |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6620 has 165.53 million shares outstanding. The number of shares has increased by 10.02% in one year.
| Current Share Class | 165.53M |
| Shares Outstanding | 165.53M |
| Shares Change (YoY) | +10.02% |
| Shares Change (QoQ) | +1.40% |
| Owned by Insiders (%) | 1.52% |
| Owned by Institutions (%) | 2.19% |
| Float | 96.01M |
Valuation Ratios
The trailing PE ratio is 16.71.
| PE Ratio | 16.71 |
| Forward PE | n/a |
| PS Ratio | 7.72 |
| PB Ratio | 2.36 |
| P/TBV Ratio | 2.73 |
| P/FCF Ratio | 58.92 |
| P/OCF Ratio | 54.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.83, with an EV/FCF ratio of 42.80.
| EV / Earnings | 12.94 |
| EV / Sales | 5.61 |
| EV / EBITDA | 8.83 |
| EV / EBIT | 10.38 |
| EV / FCF | 42.80 |
Financial Position
The company has a current ratio of 36.59, with a Debt / Equity ratio of 0.01.
| Current Ratio | 36.59 |
| Quick Ratio | 36.41 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.21 |
| Interest Coverage | 900.85 |
Financial Efficiency
Return on equity (ROE) is 17.08% and return on invested capital (ROIC) is 38.08%.
| Return on Equity (ROE) | 17.08% |
| Return on Assets (ROA) | 12.51% |
| Return on Invested Capital (ROIC) | 38.08% |
| Return on Capital Employed (ROCE) | 16.18% |
| Weighted Average Cost of Capital (WACC) | 8.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TPEX:6620 has paid 187.20 million in taxes.
| Income Tax | 187.20M |
| Effective Tax Rate | 19.98% |
Stock Price Statistics
The stock price has increased by +15.12% in the last 52 weeks. The beta is 0.85, so TPEX:6620's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +15.12% |
| 50-Day Moving Average | 75.98 |
| 200-Day Moving Average | 94.37 |
| Relative Strength Index (RSI) | 68.25 |
| Average Volume (20 Days) | 353,913 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6620 had revenue of TWD 1.73 billion and earned 749.77 million in profits. Earnings per share was 4.83.
| Revenue | 1.73B |
| Gross Profit | 1.46B |
| Operating Income | 934.18M |
| Pretax Income | 936.98M |
| Net Income | 749.77M |
| EBITDA | 1.09B |
| EBIT | 934.18M |
| Earnings Per Share (EPS) | 4.83 |
Balance Sheet
The company has 3.70 billion in cash and 47.64 million in debt, with a net cash position of 3.66 billion or 22.09 per share.
| Cash & Cash Equivalents | 3.70B |
| Total Debt | 47.64M |
| Net Cash | 3.66B |
| Net Cash Per Share | 22.09 |
| Equity (Book Value) | 5.66B |
| Book Value Per Share | 34.20 |
| Working Capital | 4.19B |
Cash Flow
In the last 12 months, operating cash flow was 243.63 million and capital expenditures -16.92 million, giving a free cash flow of 226.72 million.
| Operating Cash Flow | 243.63M |
| Capital Expenditures | -16.92M |
| Depreciation & Amortization | 164.13M |
| Net Borrowing | -13.26M |
| Free Cash Flow | 226.72M |
| FCF Per Share | 1.37 |
Margins
Gross margin is 84.53%, with operating and profit margins of 54.02% and 43.36%.
| Gross Margin | 84.53% |
| Operating Margin | 54.02% |
| Pretax Margin | 54.18% |
| Profit Margin | 43.36% |
| EBITDA Margin | 62.77% |
| EBIT Margin | 54.02% |
| FCF Margin | 13.11% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 2.48%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 2.48% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 31.52% |
| Buyback Yield | -10.02% |
| Shareholder Yield | -7.54% |
| Earnings Yield | 5.61% |
| FCF Yield | 1.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6620 has an Altman Z-Score of 38.75 and a Piotroski F-Score of 5.
| Altman Z-Score | 38.75 |
| Piotroski F-Score | 5 |